• Thomas Pendlebury

    Thomas Pendlebury

    Vice President of Sales and Marketing
    Minerva Surgical, Inc.

    Thomas Pendlebury has served as Vice President of Sales and Marketing for Minerva Surgical since October 2014. Prior to Minerva, his experience building sales and marketing organizations at start-up companies spans numerous specialties including general surgery, orthopaedics, spine, and women’s health.

    Mr. Pendlebury began his career in the medical device industry at Johnson and Johnson where he held roles in sales and marketing management in the Ethicon wound closure business; and later Hill-Rom and Synthes Orthopaedics. In 2002 he joined Novacept at the start of commercialization, and through the successful acquisition to Cytyc in 2004, where he served as Regional Business Director for both the surgical and diagnostic divisions (later acquired by Hologic).

    In 2007 he joined SurgRx which was subsequently sold to Ethicon Endo-Surgery in 2008; and later as Vice President of Sales at Nextremity Solutions; and Vice President of Sales and Marketing at Domain Surgical.

  • Management 2

    Eugene V. Skalnyi, M.D.

    Vice President of Medical Affairs
    Minerva Surgical, Inc.
    Eugene V. Skalnyi, M.D. has served as our Vice President of Medical Affairs since January 2011. Prior to joining our company, Dr. Skalnyi served as medical advisor for various companies, including Meditrina, Inc., from August 2016 to April 2020, CorRx, Inc., from January 2015 to April 2020, IoGyn, Inc. (acquired by Boston Scientific), from July 2011 to August 2017, and Pulse Therapeutic Technology, Inc., from January 2015 to January 2017. He has also served as Vice President of Medical Affairs for several companies, including Sierra Surgical Technologies, Cytyc Surgical Products (acquired by Hologic, Inc.), and Novacept Inc. (acquired by Cytyc Corporation). Dr. Skalnyi received his Medical Degree from Moldova Medical University in 1988 and sub-specialized in Advanced Operative Endoscopy in 1990.
  • Dominique J. Filloux

    Dominique J. Filloux

    Chief Operating Officer
    Minerva Surgical, Inc.
    Dominique J. Filloux serves as our Chief Operating Officer of our company. He has held various positions with the Company since 2010, including Vice President of Research & Development and Operations, and Chief Technology Officer. Prior to joining our company, he served as Director of Research & Development at Endovascular Technologies (acquired by Guidant) from 1992 to 2000, Vice President of Operations at Ventrica, Inc. from 2001 to 2004, Vice President of Research & Development and Operations at Cierra Inc. from 2004 to 2007, and Vice President of Research & Development at Arstasis, Inc. from 2007 to 2010. He holds a B.S. Degree in Applied Mechanics from the University of California at San Diego, and an M.B.A. from Santa Clara University, Leavey School of Business.
  • Veronica Williams

    Veronica Williams

    VP of Quality Assurance
    Minerva Surgical, Inc.

    Ms. Williams has over 28 years of experience in the medical device industry in the field of quality assurance. She has held various quality assurance positions at a number of startup companies developing 510(k) and PMA devices for the U.S. and International Markets including Advance Cardiovascular Systems (Abbott), Biotrack (Du Pont), Applied Immune Sciences (Sanofi-Aventis), and Cardima.

    Prior to joining Minerva in November 2009, Ms. Williams was the Director of Quality Systems for Novacept and the Director of Quality Assurance for SurgRx where she developed and implemented the Quality Management Systems and provided regulatory support that carried SurgRx and Novacept from concept to domestic and international Approvals. Ms. Williams holds a B.S. degree in Chemical Engineering with Minor in Computer Science from San Jose State University. Ms. Williams is also an ASQ certified Quality Engineer

  • Joel R. Jung

    Joel R. Jung

    Chief Financial Officer
    Minerva Surgical, Inc.
    Prior to joining our company, Mr. Jung served as the CFO at several life sciences companies including Counsyl, Inc. (acquired by Myriad Genetics, Inc.) from July 2016 to September 2018, Bionano Genomics, Inc. from February 2014 to June 2016, AgraQuest, Inc. (acquired by Bayer CropScience) from February 2010 to December 2012, and Celera Corporation from June 2008 to April 2009. He also served as Vice President of Finance with Bayer CropScience from December 2012 to June 2013, Applera Corporation-Celera Group from June 2006 to June 2008, and Chiron Corporation (acquired by Novartis) from September 1999 to April 2003, and Vice President and Treasurer of Chiron Corporation from April 2003 to July 2006. Mr. Jung holds a B.S. Degree in Aeronautical Engineering from Purdue University, and an M.B.A. from the Haas School of Business at the University of California, Berkeley.
  • Wendy Bowman

    Wendy Bowman

    VP, Human Resources
    Minerva Surgical, Inc.
    Wendy Bowman serves as our VP, Human Resources, she joined us in 2015 as Director of HR. She brings 20 years of in-house and consulting HR experience in large companies, small emerging companies and venture capital firms. Most recently, Ms. Bowman has been an HR Consultant with Christine Mathews Consulting advising leadership teams and building out HR strategies for business growth. Previously, she held roles at SurgRx (acquired by Ethicon Endo-Surgery, a Johnson & Johnson company) and Procter & Gamble. She received a B.S. in Business Administration from University of Costa Rica.
  • Joanne Long

    Joanne Long

    Vice President, Corporate Controller
    Minerva Surgical, Inc.
    Joanne Long serves as Vice President, Corporate Controller of Minerva Surgical since February 2021. She brings 10 years of experience in accounting, with a focus on health care and medical technology industry. Prior to joining Minerva Surgical, Joanne was Vice President, Corporate Controller at Carbon Health Technologies. She also held financial leadership positions at two other health care companies including Counsyl, Inc., which was acquired by Myriad Genetics, Inc. Joanne began her career in public accounting, spending 6 years at KPMG, LLP, and earned her B.S. in Accounting from University of Queensland, Australia and is an inactive Certified Public Accountant.
  • David M. Clapper

    David M. Clapper

    President and Chief Executive Officer
    Minerva Surgical, Inc.
    David M. Clapper has served as our President and Chief Executive Officer since May 2011 and has served as a member of the board of directors since October 2008. Mr. Clapper started his medical device career at Johnson & Johnson. During his 16 years at Johnson & Johnson, he held positions from Sales Representative to Vice President of Product Management, Sales, and Marketing, and a member of the board of directors of Ethicon Inc., Ethicon Endo-Surgery, and Critikon, Inc. In 1993, he became the President and CEO of Focal Inc. (Nasdaq: FOCL – acquired by Genzyme/Sanofi), a biomaterials company in Boston. In 1999, Mr. Clapper began serving as President and CEO of Novacept Inc. in Palo Alto, CA until its acquisition in 2004 by Cytyc Corporation. In 2005 Mr. Clapper began serving as the President and CEO of SurgRx, Inc. until its acquisition in December 2008, by Ethicon Endo-Surgery, Inc., a Johnson & Johnson company. In the past, he also served as a member of the board of directors at SVB Financial Group and Silicon Valley Bank (Nasdaq: SIVB), Pulmonx Corporation (Nasdaq: LUNG), Conor Medsystems, Inc. (Nasdaq: CONR—acquired by Johnson and Johnson), St. Francis Medical Technologies Inc., (acquired by Kyphon/Medtronic), Baxano, Inc. (acquired by TranS1), DFINE, Inc. (acquired by Merit Medical), IoGyn, Inc. (acquired by Boston Scientific Corporation (BSC)), Neomend, Inc. (acquired by CR Bard), Carbylan Therapeutics, Inc. (Nasdaq: CBYL – acquired by KalVista), and RELIGN Corporation (acquired by Zimmer-Biomet). Mr. Clapper is currently serving on the board of directors of Corinth MedTech. Mr. Clapper holds a B.A. in Marketing from Bowling Green State University.
back to top